multicellular
organ
face
task
safe
dispos
unwant
cell
physiolog
patholog
condit
activ
tightli
regul
cell
death
program
apoptosi
consid
play
major
role
physiolog
control
cell
turnov
end
dysregul
apoptosi
shown
contribut
pathogenesi
differ
autoimmun
diseas
last
decad
role
apoptosi
also
neuroimmunolog
diseas
clearli
defin
eae
experiment
autoimmun
neuriti
ean
especi
apoptosi
pathogen
effector
cell
thoroughli
investig
review
briefli
introduc
definit
detect
method
apoptosi
focu
apoptot
cell
death
effector
tcell
eae
propos
mechan
tcell
apoptosi
function
consequ
final
potenti
therapeut
implic
apoptosi
special
morpholog
biochem
distinct
form
eukaryot
cell
death
introduc
kerr
colleagu
term
apoptosi
serv
describ
set
morpholog
featur
commonli
observ
cell
death
variou
tissu
cell
type
differ
observ
necrot
cell
death
stereotyp
seri
cellular
chang
compris
bleb
plasma
membran
condens
chromatin
peripheri
nucleu
follow
disintegr
cell
multipl
membraneenclos
vesicl
contrast
lytic
process
observ
necrosi
cell
death
apoptosi
associ
secondari
inflammatori
tissu
respons
eg
toward
potenti
harm
intracellular
content
die
cell
thu
apoptosi
consid
provid
safe
gentl
cell
death
mechan
vivo
apoptosi
also
appear
fast
efficaci
mechan
elimin
unwant
cell
complet
cell
death
program
within
hr
least
certain
tissu
defin
condit
tradit
definit
apoptosi
mainli
base
morpholog
criteria
electron
microscopi
serv
gold
standard
detect
apoptosi
meanwhil
better
understand
underli
biochem
process
apoptosi
led
introduct
array
detect
method
molecular
level
exampl
intravit
internucleosom
dnafragment
gener
fragment
bp
multipl
thereof
reliabl
detect
use
tunel
situ
nick
translat
techniqu
identif
set
aspartatedirect
cystein
proteas
caspas
whose
activ
underli
mani
observ
morpholog
chang
apoptosi
broaden
spectrum
detect
method
thu
either
activ
caspas
proteolyt
cleavag
product
eg
cytokeratin
poli
adpribos
polymeras
parp
app
actin
cleavag
product
identifi
also
specif
alter
cell
membran
eg
loss
apoptot
cell
death
experiment
autoimmun
encephalomyel
phospholipid
asymmetri
detect
annexinv
mitochondri
chang
eg
cytochrom
c
releas
permeabl
transit
serv
basi
commerci
avail
detect
method
apoptosi
howev
mani
detect
method
interpret
cautious
exampl
dnafragment
occur
apoptosi
also
necrosi
sinc
differ
intracellular
pathway
lead
typic
apoptot
featur
combin
differ
molecular
detect
method
feasibl
thu
typic
morpholog
featur
apoptosi
also
occur
absenc
oligonucleosom
dnafragment
well
enucl
cell
tcell
autoreact
cnsantigen
mbp
also
occur
healthi
individu
albeit
often
mspatient
surg
increas
frequenc
circul
myelinreact
tcell
also
observ
healthi
subject
possibl
driven
crossreact
environment
antigen
activ
autoreact
tcell
capabl
enter
cnsparenchyma
thu
potenti
induc
local
immun
respons
encount
specif
antigen
context
appropri
restrict
molecul
therefor
special
anatom
barrier
blood
brain
barrier
absenc
lymphat
drainag
suffici
prevent
immunemedi
damag
cn
argu
mechan
physiolog
control
autoreact
inflammatori
cell
situ
local
apoptosi
pathogen
tcell
identifi
major
immunolog
defens
mechan
immuneprivileg
cn
lead
inhibit
inflamm
encroach
rapid
nondestruct
elimin
inflammatori
infiltr
review
first
report
cell
death
apoptosi
inflammatori
brain
lesion
lewi
rat
eae
pender
colleagu
use
morpholog
criteria
major
die
cell
appear
lymphocyt
oligodendrocyt
apoptosi
subsequ
confirm
group
use
preembed
immunolabel
techniqu
combin
tcell
immunohistochemistri
molecular
label
techniqu
ultrastructur
criteria
schmi
cowork
analyz
tcell
apoptosi
spinal
cord
quantit
time
cours
differ
rat
eae
model
apoptot
cell
identifi
tlymphocyt
mostli
express
cell
receptor
anoth
apoptot
cell
classifi
oligodendrocyt
apoptosi
macrophag
rare
observ
howev
consider
proport
apoptot
cell
could
identifi
immunocytochem
due
advanc
degener
cell
lewi
rat
cell
transfer
eae
use
mbpspecif
tcell
degre
tcell
apoptosi
minim
earli
stage
day
peak
time
recoveri
diseas
day
apoptosi
rate
figur
also
activ
diseas
model
preval
tcell
apoptosi
situ
highest
anim
recov
diseas
apoptosi
inflammatori
cell
situ
also
occur
chronic
relaps
eae
model
especi
clinic
relaps
cn
adopt
transfer
chronic
relaps
eae
sjlj
mice
apoptosi
tcell
microgliabrain
macrophag
could
readili
observ
oligodendrocyt
astrocyt
exhibit
tunel
posit
tcell
apoptosi
situ
identifi
eae
also
coronavirusmedi
encephalomyel
apoptosi
tlymphocyt
also
occur
inflammatori
human
brain
lesion
promin
acut
dissemin
leukoencephalomyel
adem
acut
monophas
diseas
close
mimic
patholog
chang
acut
eae
tcell
apoptosi
also
observ
activ
ms
lesion
albeit
lesser
extent
possibl
due
chronic
diseas
similar
degre
tcell
apoptosi
acut
autoimmun
inflam
rodent
eae
human
contrast
high
tcell
apoptosi
rate
observ
cn
pn
peripher
tissu
appear
lower
capac
induc
tcell
apoptosi
local
tcell
apoptosi
could
also
observ
sciatic
nerv
lewi
rat
activ
atean
wherea
time
cours
similar
eae
extent
tcell
apoptosi
markedli
differ
highest
level
also
found
recoveri
typic
tcell
rate
approxim
figur
howev
spite
lower
apoptosi
rate
also
pn
local
tcell
apoptosi
regard
effici
mechan
cell
elimin
thu
given
time
frame
hr
complet
apoptosi
one
could
assum
inflammatori
infiltr
would
elimin
within
hr
neglig
degre
tcell
apoptosi
found
tcell
mediat
autoimmun
diseas
muscular
tissu
tcell
apoptosi
less
domin
experiment
autoimmun
myositi
biopsi
differ
human
myopathi
presum
autoimmun
etiolog
thu
tcell
inflamm
muscl
clear
apoptosi
situ
could
contribut
nonselflimit
natur
diseas
even
hivassoci
polymyos
neuropathi
virtual
relev
tcell
apoptosi
situ
spite
pathophysiolog
relev
tcell
apoptosi
hivinfect
also
tcell
infiltr
skin
appear
elimin
local
apoptosi
lewi
rat
eae
neglig
tcell
apoptosi
dermal
tissu
adjac
sensit
site
despit
heavi
tcell
infiltr
furthermor
skin
biopsi
patient
dermatomyos
lupu
erythematosu
tcell
apoptosi
virtual
absent
chan
gold
unpublish
observ
given
obviou
dispar
tcell
apoptosi
immunoprivileg
cn
nonimmunolog
protect
site
tissuespecif
local
mechan
must
activ
cn
lead
effici
apoptot
clearanc
pathogen
tcell
moreov
use
mbpand
ovalbuminspecif
tcell
appear
mbpspecif
tcell
readili
elimin
cn
apoptosi
tcell
specif
ovalbumin
antigen
present
lewi
rat
surviv
cn
recircul
peripher
lymphoid
organ
howev
studi
could
exclud
also
ovalbumin
specif
tcell
underw
apoptosi
cn
also
alter
physicochem
properti
collaps
apoptot
cell
could
preclud
quantit
recoveri
spinal
cord
gradient
centrifug
moreov
mbpreactiv
tcell
receptor
element
besid
v
proven
encephalitogen
analyz
studi
use
tcell
stabli
express
specif
genom
marker
lassmann
colleagu
could
demonstr
mbpspecif
ovalbuminspecif
tcell
undergo
apoptosi
cn
eaeanim
addit
occur
tcell
apoptosi
eae
bone
marrow
chimera
differ
mhchaplotyp
resid
glial
cell
passiv
transfer
tcell
indic
tcell
apoptosi
depend
antigenspecif
mechan
thu
encephalitogen
antigenspecif
tcell
well
secondarili
recruit
bystand
tlymphocyt
appear
undergo
apoptosi
situ
molecular
mechan
lead
tcell
apoptosi
cn
situ
yet
incomplet
understood
vivo
mediat
death
pathway
appear
play
major
role
induct
tcell
apoptosi
cn
thu
eae
tnfrior
tnflymphotoxindefici
mice
local
tcell
apoptosi
decreas
tnfc
demonstr
potent
induc
tcell
apoptosi
follow
line
administr
antitnfc
antibodi
decreas
local
tcell
apoptosi
eae
lewi
rat
undergo
highdos
antigentherapi
mbp
releas
high
amount
tnfc
observ
situ
tcell
apoptosi
cn
may
also
mediat
via
fasfa
ligand
pathway
review
thu
one
propos
mechan
ligat
tcell
express
host
cell
sinc
tcell
apoptosi
appear
tissu
specif
resid
glial
cell
might
sensit
tcell
toward
cell
death
directli
solubl
factor
antigen
present
mbpspecif
tcell
rat
microglia
result
tcell
apoptosi
vitro
prevent
exogen
also
astrocyt
act
nonprofession
antigen
present
cell
apc
render
tcell
suscept
apoptosi
induc
glucocorticosteroid
vitro
glucocorticosteroid
markedli
increas
tcell
apoptosi
ad
tcell
astrocyt
cocultur
late
tcell
activ
stage
wherea
effect
thymu
cell
use
antigen
present
result
could
argu
scenario
infiltr
tcell
prime
apoptot
stimulu
resid
nonprofession
apc
subsequ
undergo
apoptosi
hormon
influenc
microenviron
system
chang
howev
tcell
apoptosi
recoveri
eae
also
occur
cn
adrenalectom
anim
argu
addit
mechan
among
other
propos
mechan
local
cn
tcell
apoptosi
compris
action
reactiv
oxygen
intermedi
nitric
oxid
cell
death
due
depriv
growth
factor
yet
precis
role
differ
put
mechan
well
date
unknown
cnsspecif
factor
induct
tcell
apoptosi
remain
elucid
high
degre
apoptosi
inflammatori
cell
autoimmun
inflam
human
rodent
cn
rais
need
effici
tightli
control
remov
mechan
unwant
cell
key
event
resolut
inflammatori
infiltr
nonphlogist
thu
safe
phagocyt
clearanc
die
yet
intact
leukocyt
undergo
apoptosi
review
apoptosi
label
unwant
cell
signal
direct
recognit
uptak
subsequ
degrad
tissuespecif
phagocyt
thu
prevent
spill
potenti
harm
content
inhibit
secondari
immun
respons
direct
toward
die
cell
addit
mere
clear
cell
remnant
ingest
apoptot
cell
also
activ
elicit
phagocyt
respons
modul
immun
reaction
inflamm
lewi
rat
eae
phagocytosi
apoptot
lymphocyt
macrophagesmicroglia
oligodendrocyt
astrocyt
situ
first
describ
electron
microscopi
use
vitro
phagocytosi
model
investig
phagocytosi
apoptot
tcell
differ
glial
cell
element
function
consequ
lewi
rat
microglia
effici
phagocytos
specif
apoptot
encephalitogen
mbpspecif
tcell
process
differenti
regul
cytokin
phagocytosi
apoptot
tcell
lewi
rat
microglia
effici
glial
cell
element
astrocyt
moreov
phagocytosi
apoptot
tcell
lead
profound
downregul
microgli
immun
function
suppress
proinflammatori
cytokin
microgli
tcell
activ
thu
silenc
microgli
phagocyt
inflammatori
context
figur
tcell
undergo
apoptosi
exhibit
specif
eat
recognit
signal
phagocyt
phagocytosi
microglia
differenti
regul
cytokin
wast
dispos
uptak
apoptot
cell
lead
downregul
differ
microgli
immunefunct
modul
immun
respons
astrocyt
lower
capac
phagocytos
apoptot
cell
may
provid
backup
mechan
modifi
vitro
rat
microgliabrain
macrophag
also
demonstr
phagocytos
apoptot
neuron
via
lectin
integrin
phosphatidylserinedepend
mechan
current
therapeut
approach
presum
immunemedi
demyelin
diseas
cn
ms
aim
rapid
termin
inflammatori
process
therebi
hasten
clinic
recoveri
potenti
also
prevent
subsequ
demyelin
axon
tissu
damag
glucocorticosteroid
gs
potent
antiinflammatori
drug
whose
therapeut
efficaci
neuroimmunolog
diseas
especi
establish
immun
neuropathi
ms
lupu
erythematosu
cerebr
vascul
intraven
administ
highdos
gs
serv
current
mainstay
therapi
acut
msrelaps
gs
mediat
pleiotrop
antiinflammatori
effect
via
differ
mechan
eg
modul
cell
activ
cytokin
express
secret
inflammatori
mediat
leucocyt
migrat
reduct
local
edema
effect
mediat
via
cytosol
gsreceptor
gsr
block
gsr
antagonist
ru
low
gs
concentr
higher
concentr
gs
appear
induc
cell
death
directli
possibl
via
nongenom
physicochem
mediat
effect
plasma
membran
lewi
rat
eae
iv
methylprednisolon
mp
therapi
administ
clinic
diseas
maximum
increas
tcell
apoptosi
spinal
cord
situ
decreas
tcell
infiltr
effect
clearli
dosedepend
dosag
least
mgkg
bodi
weight
mp
requir
achiev
increas
tcell
apoptosi
margin
decreas
tcell
infiltr
higher
dosag
mgkg
bodi
weight
mp
superior
respect
also
effect
mild
eae
contrast
lower
dosag
mp
strong
apoptosispromot
effect
gs
also
demonstr
peripher
blood
leukocyt
pbl
mspatient
intraven
highdos
corticosteroid
treatment
apoptosi
pbl
markedli
augment
differ
mssubgroup
predominantli
affect
cell
also
peripher
nervou
system
highdos
gs
augment
tcell
apoptosi
lewi
rat
ean
increas
tcell
apoptosi
could
observ
sciatic
nerv
therapeut
administr
gs
mgkg
bodi
weight
prednisolon
similar
result
could
observ
lewi
rat
experiment
autoimmun
myositi
eam
model
human
idiopath
myosit
presum
autoimmuneinflammatori
etiolog
clear
increas
apoptot
endomysi
tcell
could
demonstr
apoptot
tcell
indic
glucocorticosteroid
also
induc
apoptosi
even
organ
normal
tcell
apoptosi
occur
type
interferon
ifn
ifn
one
current
mainstay
immunomodulatori
therapi
ms
ifn
appear
affect
particularli
inflammatori
aspect
ms
reduct
relaps
rate
posit
effect
inflammatori
chang
observ
mri
scan
experiment
model
ifn
shown
inhibit
progress
relapsingremit
eae
earli
discontinu
ifn
led
exacerb
activ
eae
exact
mechan
action
ifn
still
unknown
numer
put
mechan
propos
review
whether
therapeut
benefit
ifn
also
base
induct
apoptosi
inflammatori
cell
still
controversi
discuss
lewi
rat
atea
major
increas
tcell
apoptosi
situ
could
observ
treatment
ifn
howev
ifn
clearli
increas
phagocytosi
apoptot
encephalitogen
mbpspecif
tcell
microglia
vitro
chan
seguin
r
submit
thu
theoret
could
help
engulf
elimin
tcell
driven
apoptosi
therapeut
use
agent
eg
corticosteroid
antigenspecif
therapi
cn
pnsautoantigen
shown
effect
eae
ean
underli
mechan
appear
involv
tcell
receptor
reengag
appropri
stage
cell
cycl
lead
tcell
apoptosi
lewi
rat
cell
transfer
eae
high
dose
antigen
guinea
pig
mbp
therapi
led
apoptot
cell
death
invad
tcell
situ
also
resid
oligodendrocyt
accompani
profound
modul
cytokin
network
rapid
induct
thltype
cytokin
tnf
ifn
well
induc
nitic
oxid
synthas
neutral
tnfc
vivo
led
decreas
tcell
oligodendrocyt
apoptosi
chang
benefici
clinic
effect
highdos
antigen
therapi
argu
central
role
tnfc
mediat
local
apoptosi
may
differ
function
effect
similar
result
could
also
observ
antigenspecif
therapi
lewi
rat
atean
use
apoptosi
inflammatori
effector
cell
constitut
effect
protect
mechan
autoimmuneinflam
cn
thu
select
apoptot
cell
death
experiment
autoimmun
encephalomyel
induct
apoptosi
pathogen
cell
attract
therapeut
target
neuroimmunolog
diseas
howev
apoptosi
resid
cn
cell
repres
also
major
mechan
pathogenesi
differ
neurodegen
disord
select
blockad
apoptot
pathway
may
benifici
therefor
identif
molecular
tissueand
cellspecif
factor
lead
local
apoptosi
remain
elucid
order
take
advantag
phylogenet
old
import
defens
mechan
